Summary
TBCK-related neurodevelopmental disorder (TBCK-NDD), also known as TBCK syndrome or TBCK encephaloneuronopathy, is a rare genetic disorder that causes significant developmental delays, low muscle tone, intellectual disability, and often progressive neurological decline. It is caused by variations in the TBCK gene, which plays a role in cell growth and brain development. Children with TBCK syndrome typically have severe motor and cognitive impairment, feeding difficulties, and distinctive facial features. There is no cure, but supportive therapies can help improve comfort and quality of life.
Description
In TBCK-NDD variants in the TBCK gene disrupt normal brain and muscle development. The TBCK gene helps regulate important cellular pathways for growth and survival. When it does not work properly, the brain’s white matter and other tissues are affected, leading to a type of neurodegeneration. There are no formal subtypes, but some children have a more severe, rapidly progressive form, while others have a slower course. The disorder is not usually fatal in infancy but can shorten lifespan due to complications like respiratory failure.
Signs and Symptoms
Diagnosis is based on genetic testing, clinical features, and brain imaging. Common symptoms include:
- Severe global developmental delay (difficulty with movement, speech, and learning)
- Profound low muscle tone (hypotonia) from birth
- Feeding difficulties and failure to thrive
- Intellectual disability (often severe)
- Seizures (in about half of cases)
- Weak or absent reflexes
- Distinctive facial features (such as a broad nasal bridge, full cheeks, and downturned mouth)
- Respiratory problems, including frequent infections and breathing weakness
- Progressive loss of skills (neurodegeneration) in some children
Early signs may be subtle, such as poor head control or delayed milestones. Over time, children may lose abilities they once had.
Causes
TBCK syndrome is caused by variations in both copies of the TBCK gene (autosomal recessive inheritance). Most affected children have parents who are healthy carriers. The disorder is not caused by anything a parent does and is not linked to environmental factors.
Laboratory Investigations
Diagnosis and monitoring may include:
Genetic testing
Whole exome sequencing, genome sequencing or targeted gene panels to identify TBCK variants.
EEG
To check if seizures are present.
Brain MRI
Shows abnormal white matter and brain atrophy.
Metabolic tests
To rule out other causes of neurodegeneration.
Genetic testing is usually done once if diagnostic. Imaging and EEG may be repeated to monitor progression or new symptoms.
Treatment and Therapies
There is no cure, so treatment focuses on managing symptoms and improving quality of life:
- Physical, occupational, and speech therapy: To maximize abilities and comfort
- Feeding support: Including feeding tubes if needed
- Seizure management: Anti-seizure medications if necessary
- Respiratory support: Such as suctioning, oxygen, or ventilator assistance for breathing problems
- Nutritional support: To address failure to thrive
- Palliative care: For severe cases or progressive decline
Side effects depend on the treatments used. Without supportive care, complications like aspiration pneumonia or malnutrition may occur. Most children need lifelong, multidisciplinary care.
Outlook
TBCK syndrome is a lifelong, typically progressive disorder. Most children have severe disabilities and require full-time care. Some may lose skills over time, and life expectancy can be reduced due to respiratory complications. Children are unlikely to live independently as adults. The disorder affects daily routines, school, and family life. Special education and therapy services are important. Diet and exercise cannot cure TBCK syndrome, but good nutrition and supportive therapies can help maintain health and comfort.
Resources
The TBCK Foundation is dedicated to serving families impacted by TBCK Syndrome through accelerating patient-led research, advocacy, education, and a dynamic system of support.
The links and resources included in this section are solicited directly from the community by the Child Neurology Foundation through a formal submission process. CNF reserves the right to remove entities at any time if information is deemed inappropriate or inconsistent with the mission, vision, and values of CNF. The authors listed on this page have not endorsed the resources or links provided in this section.
Research
ClinicalTrials.gov for TBCK Syndrome (birth to 17 years)
These are clinical trials that are recruiting or will be recruiting. Updates are made daily, so you are encouraged to check back frequently.
ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. This is a resource provided by the U.S. National Library of Medicine (NLM), which is an institute within the National Institutes of Health (NIH). Listing a study does not mean it has been evaluated by the U.S. Federal Government. Please read the NLM disclaimer for details.
Before participating in a study, you are encouraged to talk to your health care provider and learn about the risks and potential benefits.
For more information about participation in clinical trials, check out our education hub on the topic here.
Family Stories
The information in the CNF Child Neurology Disorder Directory is not intended to provide diagnosis, treatment, or medical advice and should not be considered a substitute for advice from a healthcare professional. Content provided is for informational purposes only. CNF is not responsible for actions taken based on the information included on this webpage. Please consult with a physician or other healthcare professional regarding any medical or health related diagnosis or treatment options.
References
- National Organization for Rare Disorders. TBCK-related encephalopathy [Internet]. Danbury (CT): National Organization for Rare Disorders; 2023 [cited 2025 Jun 24]. Available from: https://rarediseases.org/rare-diseases/tbck-related-encephalopathy/
- Chong JX, Caputo V, Phelps IG, et al. Recessive mutations in TBCK, encoding a Rab GTPase-activating protein, cause severe infantile syndromic encephalopathy. Am J Hum Genet. 2016 Apr 7;98(4):772-81. doi:10.1016/j.ajhg.2016.02.014. PMID: 27040692; PMCID: PMC4833215.
- Guerreiro RJ, Brown R, Dian D, et al. Mutation of TBCK causes a rare recessive developmental disorder. Neurology. 2016 Jul 26;87(4):176-182. doi:10.1212/WNL.0000000000002858. PMID: 27281532; PMCID: PMC4967197.
- TBCK-related encephalopathy [Internet]. Boston (MA): FDNA; 2024 [cited 2025 Jun 24]. Available from: https://fdna.com/health/
- TBCK-Related Neurodevelopmental Disorder – GeneReviews® – NCBI Bookshelf
- Perplexity AI, Inc. Perplexity [Internet]. San Francisco (CA): Perplexity AI, Inc.; 2025 [cited 2025 Oct 24]. Available from: https://www.perplexity.ai
This overview is for general information and is not a substitute for advice from your child's care team.
← Back to the Disorder Directory